From Discovery To Recognition: Two Roads To A Nobel

The number of years that a physicist or chemist waits between the completion of breakthrough research and recognition for that work by the Nobel Committee has been averaging about a dozen years since 1945. This year’s physics prize, however, was awarded for an experiment performed some 26 years ago, while the chemistry prize came for discoveries attained rather recently—between 1982 and 1985. The physics prize was jointly awarded to three Americans: Leon M. Lederman, 66, Fermi N

Written byDavid Pendlebury
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The number of years that a physicist or chemist waits between the completion of breakthrough research and recognition for that work by the Nobel Committee has been averaging about a dozen years since 1945. This year’s physics prize, however, was awarded for an experiment performed some 26 years ago, while the chemistry prize came for discoveries attained rather recently—between 1982 and 1985.

The physics prize was jointly awarded to three Americans: Leon M. Lederman, 66, Fermi National Accelerator Laboratory in Batavia, 111.; Jack Steinberger, 67, CERN in Geneva; and Melvin Schwartz, 56, Digital Pathways Inc. in Mountain View, Calif. Their work took place in 1962 at the Brookhaven National Accelerator Laboratory in Upton, Long Island, N.Y There Lederman, Steinberger, and Schwartz led a team of scientists in a landmark experiment that, in the words of the Nobel Committee’s statement, “opened entirely new opportunities for research into the innermost structure and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies